Lisa M. Schwartz

15.5k total citations · 6 hit papers
130 papers, 10.2k citations indexed

About

Lisa M. Schwartz is a scholar working on Economics and Econometrics, Oncology and General Health Professions. According to data from OpenAlex, Lisa M. Schwartz has authored 130 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Economics and Econometrics, 28 papers in Oncology and 22 papers in General Health Professions. Recurrent topics in Lisa M. Schwartz's work include Global Cancer Incidence and Screening (22 papers), Health Systems, Economic Evaluations, Quality of Life (21 papers) and Pharmaceutical industry and healthcare (19 papers). Lisa M. Schwartz is often cited by papers focused on Global Cancer Incidence and Screening (22 papers), Health Systems, Economic Evaluations, Quality of Life (21 papers) and Pharmaceutical industry and healthcare (19 papers). Lisa M. Schwartz collaborates with scholars based in United States, Germany and Canada. Lisa M. Schwartz's co-authors include Steven Woloshin, H. Gilbert Welch, Renda Soylemez Wiener, Wolfgang Gaissmaier, Gerd Gigerenzer, Elke Kurz‐Milcke, Brenda Sirovich, Deborah L. Ornstein, Leo R. Zacharski and Cláudia Jacques Lagranha and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Lisa M. Schwartz

129 papers receiving 9.8k citations

Hit Papers

The Role of Numeracy in U... 1997 2026 2006 2016 1997 2007 2004 2011 2011 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Role of Numeracy in Understanding the Benefit of Screening Mammography
    1997 868 citations Lisa M. Schwartz et al. Annals of Internal Medicine profile →
  2. Helping Doctors and Patients Make Sense of Health Statistics
    2007 811 citations Lisa M. Schwartz, Steven Woloshin et al. PubMed profile →
  3. Enthusiasm for Cancer Screening in the United States
    2004 507 citations Lisa M. Schwartz JAMA profile →
  4. Time Trends in Pulmonary Embolism in the United States
    2011 462 citations Renda Soylemez Wiener, Lisa M. Schwartz et al. Archives of Internal Medicine profile →
  5. Population-Based Risk for Complications After Transthoracic Needle Lung Biopsy of a Pulmonary Nodule: An Analysis of Discharge Records
    2011 360 citations Renda Soylemez Wiener, Lisa M. Schwartz et al. Annals of Internal Medicine profile →
  6. Medical Marketing in the United States, 1997-2016
    2019 217 citations Lisa M. Schwartz, Steven Woloshin JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa M. Schwartz United States 53 2.5k 2.2k 1.6k 1.4k 1.2k 130 10.2k
Steven Woloshin United States 52 2.4k 1.0× 1.9k 0.8× 1.6k 1.0× 1.4k 1.0× 1.2k 1.0× 145 9.9k
Jennifer S. Haas United States 55 3.1k 1.2× 2.3k 1.0× 1.7k 1.1× 1.0k 0.7× 2.0k 1.6× 229 10.7k
Rebecca A. Silliman United States 56 1.7k 0.7× 4.0k 1.8× 1.2k 0.7× 1.3k 0.9× 1.2k 1.0× 177 9.7k
Harold C. Sox United States 47 2.3k 0.9× 1.1k 0.5× 2.1k 1.3× 1.3k 0.9× 2.1k 1.7× 122 14.7k
Jon Emery Australia 50 2.2k 0.9× 4.4k 2.0× 1.1k 0.7× 1.0k 0.7× 2.0k 1.6× 330 10.4k
Katrina Armstrong United States 58 2.6k 1.1× 2.8k 1.3× 1.4k 0.9× 1.5k 1.1× 1.7k 1.4× 252 11.2k
Richard Sullivan United Kingdom 54 2.0k 0.8× 4.5k 2.0× 3.1k 1.9× 1.7k 1.2× 1.7k 1.4× 459 15.5k
Timothy L. Lash United States 60 973 0.4× 3.6k 1.6× 1.2k 0.7× 1.4k 1.0× 1.6k 1.3× 348 15.0k
Kevin P. Weinfurt United States 50 2.0k 0.8× 1.7k 0.8× 928 0.6× 717 0.5× 2.0k 1.6× 207 9.3k
A. Simon Pickard United States 50 2.1k 0.9× 1.0k 0.5× 3.9k 2.4× 1.1k 0.8× 946 0.8× 211 10.5k

Countries citing papers authored by Lisa M. Schwartz

Since Specialization
Citations

This map shows the geographic impact of Lisa M. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa M. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa M. Schwartz more than expected).

Fields of papers citing papers by Lisa M. Schwartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa M. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa M. Schwartz. The network helps show where Lisa M. Schwartz may publish in the future.

Co-authorship network of co-authors of Lisa M. Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa M. Schwartz. A scholar is included among the top collaborators of Lisa M. Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa M. Schwartz. Lisa M. Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schwartz, Lisa M., et al.. (2019). Randomized Study of Providing Evidence Context to Mitigate Physician Misinterpretation Arising From Off-Label Drug Promotion. Circulation Cardiovascular Quality and Outcomes. 12(11). e006073–e006073. 4 indexed citations
2.
Woloshin, Steven & Lisa M. Schwartz. (2018). Overcoming overuse: the way forward is not standing still—an essay by Steven Woloshin and Lisa M Schwartz. BMJ. 361. k2035–k2035. 3 indexed citations
3.
Brodersen, John, Lisa M. Schwartz, & Steven Woloshin. (2014). Overdiagnosis: How cancer screening can turn indolent pathology into illness. Apmis. 122(8). 683–689. 61 indexed citations
4.
Woloshin, Steven, et al.. (2014). Using Radiology Reports to Encourage Evidence-based Practice in the Evaluation of Small, Incidentally Detected Pulmonary Nodules. A Preliminary Study. Annals of the American Thoracic Society. 11(2). 211–214. 25 indexed citations
5.
Woloshin, Steven, Lisa M. Schwartz, William C. Black, & Barnett S. Kramer. (2012). Cancer Screening Campaigns — Getting Past Uninformative Persuasion. New England Journal of Medicine. 367(18). 1677–1679. 68 indexed citations
6.
Wiener, Renda Soylemez, Lisa M. Schwartz, Steven Woloshin, & H. Gilbert Welch. (2011). Population-based risk of complications following transthoracic needle lung biopsy of a pulmonary nodule. Annals of Internal Medicine. 155(3). 137. 16 indexed citations
7.
Siegel, Corey A., Lisa M. Schwartz, Steven Woloshin, et al.. (2010). When should ulcerative colitis patients undergo colectomy for dysplasia? Mismatch between patient preferences and physician recommendations. Inflammatory Bowel Diseases. 16(10). 1658–1662. 38 indexed citations
8.
Schwartz, Lisa M. & Steven Woloshin. (2009). Lost in Transmission — FDA Drug Information That Never Reaches Clinicians. New England Journal of Medicine. 361(18). 1717–1720. 29 indexed citations
9.
Woloshin, Steven, Lisa M. Schwartz, & H. Gilbert Welch. (2008). Know Your Chances. 6 indexed citations
10.
Woloshin, Steven, Lisa M. Schwartz, & H. Gilbert Welch. (2008). The Risk of Death by Age, Sex, and Smoking Status in the United States: Putting Health Risks in Context. JNCI Journal of the National Cancer Institute. 100(12). 845–853. 99 indexed citations
11.
Larson, Robin J., Steven Woloshin, Lisa M. Schwartz, & H. Gilbert Welch. (2005). Celebrity Endorsements of Cancer Screening. JNCI Journal of the National Cancer Institute. 97(9). 693–695. 63 indexed citations
12.
Shenson, Douglas, Michael H. Alderman, Grant T. Fankhauser, et al.. (2004). The Public's Enthusiasm for Cancer Screening [3] (multiple letters). JAMA. 291(15). 1835–1836. 1 indexed citations
13.
Woloshin, Steven, Lisa M. Schwartz, & H. Gilbert Welch. (2003). Modeling Sound Source Localization under the Precedence Effect Using Multivariate Gaussian Mixtures. Journal of the Audio Engineering Society. 20(11). 996–1000. 45 indexed citations
14.
Sirovich, Brenda, Lisa M. Schwartz, & Steven Woloshin. (2003). Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?. PubMed. 289(11). 1414–20. 281 indexed citations
15.
16.
Schwartz, Lisa M., et al.. (2002). Media Coverage of Scientific Meetings. JAMA. 287(21). 2859–2859. 64 indexed citations
17.
Schwartz, Lisa M.. (2000). US women's attitudes to false-positive mammography results and detection of ductal carcinoma in situ: cross-sectional survey. Western Journal of Medicine. 173(5). 307–312. 26 indexed citations
18.
Woloshin, Steven & Lisa M. Schwartz. (1999). The U.S. Postal Service and Cancer Screening — Stamps of Approval?. New England Journal of Medicine. 340(11). 884–887. 19 indexed citations
19.
Schwartz, Lisa M.. (1996). Trends in Diagnostic Testing Following a National Guideline for Evaluation of Dyspepsia. Archives of Internal Medicine. 156(8). 873–873. 9 indexed citations
20.
Becker, Bernhard F., et al.. (1993). Postischemic dysfunction of the heart induced by small numbers of neutrophils via formation of hypochlorous acid. Basic Research in Cardiology. 88(4). 321–339. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven Woloshin Breakdown of academic impact, for papers by Jennifer S. Haas Breakdown of academic impact, for papers by Rebecca A. Silliman Breakdown of academic impact, for papers by Harold C. Sox Breakdown of academic impact, for papers by Jon Emery Breakdown of academic impact, for papers by Katrina Armstrong Breakdown of academic impact, for papers by Richard Sullivan Breakdown of academic impact, for papers by Timothy L. Lash Breakdown of academic impact, for papers by Kevin P. Weinfurt Breakdown of academic impact, for papers by A. Simon Pickard
Rankless by CCL
2026